Unlock regulatory insights with Watson. Learn More
Return to Docket

Requests That the FDA Issue a Federal Regulation to Place Naloxone Injected or Given Nasally to Reverse an Opioid Overdose Behind the Pharmacy Counter in Addition to Prescription use.

Abstract: Closed Petition Denied 3/31/2015
Type: Non-Rule Making
Docket Item Code P
Center CDER


Click here to view all comments of this document.